Regulus Therapeutics Inc. (RGLS)
RGLS Stock Chart More Charts
RGLS Price/Volume Stats
| Current price | $0.70 |
| Prev. close | $0.69 |
| Day low | $0.69 |
| Day high | $0.73 |
| 50-day MA | $0.69 |
| 200-day MA | $0.99 |
| 52-week high | $1.52 |
| 52-week low | $0.61 |
| Volume | 5,811 |
| Avg. volume | 455,121 |
| Dividend yield | N/A |
| Market Cap | 73.02M |
RGLS Returns
| 1-mo | -2.23% |
| 3-mo | -16.17% |
| 6-mo | -27.08% |
| 1-year | -30.69% |
| 3-year | -93.06% |
| 5-year | -93.07% |
| YTD | -32.69% |
| 2017 | -53.78% |
| 2016 | -74.20% |
| 2015 | -45.64% |
| 2014 | 117.05% |
| 2013 | 17.30% |
Regulus Therapeutics Inc. (RGLS) Company Bio
Regulus Therapeutics is a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs. The company was founded in 2007 and is based in San Diego, California.
Loading social stream, please wait...